Companion diagnostic has the potential to totally modify the drug development process and commercialization of the drug diagnoses will make drugs with a better therapeutic efficiency in a faster and cost-effective way. Companion diagnostics has been extremely advantageous to identify patients with precise biomarkers that have predictive responses. A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.
Key factors which affects and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are Innovative technologies such as next-generation sequencing (NGS), growing acceptance of companion diagnostic kits/tests by the pharmaceutical industry and boost from controlling bodies are anticipated to enhance the market. NGS-based companion diagnostics is one of the major factors that will drive the market due to its ability of identifying multiple genes at a single time. Regulatory uncertainty and cost allied with developing drugs are expected to hamper the market growth of companion diagnostic market.
For granular level understanding the Companion Diagnostics Market is segmented based on indications and technology, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Indications: • Oncology o Colorectal Cancer o Breast Cancer o Lung Cancer o Gastric Cancer o Melanoma • Inflammation and Autoimmune Diseases • Cardiovascular Diseases • Central Nervous System Disorders • Virology Diseases
Based on Technology: • Immuno Histochemistry • Molecular Diagnostics o In-Situ Hybridization o Real Time PCR o Gene Sequencing
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, KSA, UAE, Nigeria and Algeria.
Some of the key players that operate in the Middle-East and Africa Companion Diagnostics market include Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others. In Feb 2017, Thermo Fisher Scientific Inc., the world leader in serving science, completed its previously announced acquisition of Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction. The business will be integrated into Thermo Fisher’s Life Sciences Solutions Segment.
The Middle-East and Africa Companion Diagnostics Market report offers wide-range of scope:
• Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of indications, technology along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Diagnostics Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
